EcoDrugPlus

Sodium Channel Protein Type 8 Subunit Alpha-Like

Ensembl ID : ENSSPAG00000001829
Gene Symbol: LOC103376591
2 Cross references
216 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSSPAG00000000360
Gene Symbol: SCN4A
3 Cross references
133 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSSPAG00000007872
Gene Symbol: SCN8A
4 Cross references
215 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSSPAG00000019874
Gene Symbol: LOC103368778
3 Cross references
205 Possible Orthologues:

Sodium- And Chloride-Dependent Glycine Transporter 1-Like

Ensembl ID : ENSSPAG00000020604
Gene Symbol: LOC103370500
3 Cross references
207 Possible Orthologues:

Sodium-Dependent Serotonin Transporter-Like

Ensembl ID : ENSSPAG00000015596
Gene Symbol: LOC103359260
3 Cross references
201 Possible Orthologues:

Sodium/hydrogen Exchanger 3-Like

Ensembl ID : ENSSPAG00000014964
Gene Symbol: LOC103360144
3 Cross references
234 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1-Like

Ensembl ID : ENSSPAG00000007272
Gene Symbol: LOC103358974
2 Cross references
181 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233-Like

Ensembl ID : ENSSPAG00000014210
Gene Symbol: LOC103355854
3 Cross references
220 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSSPAG00000001782
Gene Symbol: LOC103356916
3 Cross references
236 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSSPAG00000022117
Gene Symbol: LOC103360230
3 Cross references
232 Possible Orthologues:

Solute Carrier Family 10 Member 2

Ensembl ID : ENSSPAG00000012785
Gene Symbol: SLC10A2
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).